News
Current information:
AGNP-Psychopharmakologie-Tage 24. – 25. Juni 2022
Mercure Hotel Moa Berlin
Website
14. TDM-Symposium der AGNP 22. – 24. Juni 2022
Jugendherberge Rheinpromenade Mannheim
Website
The Competence network "TDM KJP" offers for members:
- Blood analyses for psychotropic drugs
- Information on TDM and expert advice in pathological findings
- Additional pharmakogenetic diagnostic investigations in special cases
- Quality management:
Access to an internetbased data registry for standardised documentation of pharmacological data in child and youth psychiatry - Data management and export for implemented research-projects
- Regular meetings and educational seminars for clinical investigators
Membership is based on active participation in data collection for the internet based data registry.
Aims of Therapeutic Drug Monitoring (TDM)
- standardized documentation of psychopharmacological treatment of children and adolescents in an internet data base:
- demographic characteristics
- clinical efficacy of the medication
- unwanted side effects
- serum levels
- improvement of dosage finding
- prevention of severe adverse events, minimization of unwanted side effects
- data collection for scientific purpose
- definition of age specific therapeutic ranges of plasma or serum levels in order to maximize clinical effects whilst minimizing the risk of side effects or toxicity
- additional pharmacogenetic analyses in individuals with inadequate serum levels